GROENHUYSEN WILHELMUS CM 4
4 · NovoCure Ltd · Filed Mar 5, 2024
Insider Transaction Report
Form 4
NovoCure LtdNVCR
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Transactions
- Sale
Ordinary Shares
[F1]2024-03-01$16.03/sh−2,107$33,769→ 252,452 total - Sale
Ordinary Shares
[F1]2024-03-04$16.01/sh−1,217$19,484→ 251,235 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Signature
Steven Robbins, as attorney in fact for Groenhuysen, Wilhelmus CM|2024-03-05